Catalyst Wire Dossier Catalyst Wire Dossier

OZEMPIC

semaglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

58 regulatory and trial events tracked for OZEMPIC, covering 2014-06-25 to 2026-08-25. Get the full timeline:

Most recent: EMA Authorised: Ozempic (semaglutide) — Novo Nordisk A/S

See pricing